These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10393452)

  • 41. Safety and efficacy of adapalene 0.1% / benzoyl peroxide 2.5% in the long-term treatment of predominantly moderate acne with or without concomitant medication - results from the non-interventional cohort study ELANG.
    Gollnick HP; Friedrich M; Peschen M; Pettker R; Pier A; Streit V; Jöstingmeyer P; Porombka D; Rojo Pulido I; Jäckel A
    J Eur Acad Dermatol Venereol; 2015 Jun; 29 Suppl 4():15-22. PubMed ID: 26059730
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of benzoyl peroxide 5% clindamycin combination gel versus adapalene 0.1% on quality of life in patients with mild to moderate acne vulgaris: a randomized single-blind study.
    Guerra-Tapia A
    J Drugs Dermatol; 2012 Jun; 11(6):714-22. PubMed ID: 22648218
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Preadolescent moderate acne vulgaris: a randomized trial of the efficacy and safety of topical adapalene-benzoyl peroxides.
    Eichenfield LF; Draelos Z; Lucky AW; Hebert AA; Sugarman J; Stein Gold L; Rudisill D; Liu H; Manna V
    J Drugs Dermatol; 2013 Jun; 12(6):611-8. PubMed ID: 23839175
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Short-term combination therapy and long-term relapse prevention in the treatment of severe acne vulgaris.
    Tan J; Stein Gold L; Schlessinger J; Brodell R; Jones T; Cruz A; Kerrouche N; Jarratt M
    J Drugs Dermatol; 2012 Feb; 11(2):174-80. PubMed ID: 22270198
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The evolution of benzoyl peroxide therapy.
    Tanghetti E
    Cutis; 2008 Nov; 82(5 Suppl):5-11. PubMed ID: 19202772
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A multicenter, double-blind study to evaluate the efficacy and safety of 2 treatments in participants with mild to moderate acne vulgaris.
    Draelos ZD; Shalita AR; Thiboutot D; Oresajo C; Yatskayer M; Raab S
    Cutis; 2012 Jun; 89(6):287-93. PubMed ID: 22838094
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy and tolerability of fixed-combination acne treatment in adolescents.
    Gold LS
    Cutis; 2013 Mar; 91(3):152-9. PubMed ID: 23617089
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A fixed-dose combination of adapalene 0.1%-BPO 2.5% allows an early and sustained improvement in quality of life and patient treatment satisfaction in severe acne.
    Brodell RT; Schlosser BJ; Rafal E; Toth D; Tyring S; Wertheimer A; Kerrouche N; Bucher D
    J Dermatolog Treat; 2012 Feb; 23(1):26-34. PubMed ID: 22103674
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Preparation and comparative clinical evaluation of liposomal gel of benzoyl peroxide for acne.
    Patel VB; Misra AN; Marfatia YS
    Drug Dev Ind Pharm; 2001 Sep; 27(8):863-9. PubMed ID: 11699839
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effective and safe combination therapy for severe acne vulgaris: a randomized, vehicle-controlled, double-blind study of adapalene 0.1%-benzoyl peroxide 2.5% fixed-dose combination gel with doxycycline hyclate 100 mg.
    Gold LS; Cruz A; Eichenfield L; Tan J; Jorizzo J; Kerrouche N; Dhuin JC
    Cutis; 2010 Feb; 85(2):94-104. PubMed ID: 20349684
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The development and optimization of a fixed combination of clindamycin and benzoyl peroxide aqueous gel.
    Bucks D; Sarpotdar P; Yu K; Angel A; Del Rosso J
    J Drugs Dermatol; 2009 Jul; 8(7):634-8. PubMed ID: 19588639
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adapalene-benzoyl peroxide once-daily, fixed-dose combination gel for the treatment of acne vulgaris: a randomized, bilateral (split-face), dose-assessment study of cutaneous tolerability in healthy participants.
    Andres P; Pernin C; Poncet M
    Cutis; 2008 Mar; 81(3):278-84. PubMed ID: 18441854
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Safety and efficacy of micronized tretinoin gel (0.05%) in treating adolescent acne.
    Torok HM; Pillai R
    J Drugs Dermatol; 2011 Jun; 10(6):647-52. PubMed ID: 21637905
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment of moderate to severe acne vulgaris in a Hispanic population: a post-hoc analysis of efficacy and tolerability of clindamycin phosphate 1.2%/benzoyl peroxide 2.5% gel.
    Cook-Bolden FE
    J Drugs Dermatol; 2012 Apr; 11(4):455-9. PubMed ID: 22453581
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Successful co-encapsulation of benzoyl peroxide and chloramphenicol in liposomes by a novel manufacturing method - dual asymmetric centrifugation.
    Ingebrigtsen SG; Škalko-Basnet N; de Albuquerque Cavalcanti Jacobsen C; Holsæter AM
    Eur J Pharm Sci; 2017 Jan; 97():192-199. PubMed ID: 27866016
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The efficacy of adapalene-benzoyl peroxide combination increases with number of acne lesions.
    Feldman SR; Tan J; Poulin Y; Dirschka T; Kerrouche N; Manna V
    J Am Acad Dermatol; 2011 Jun; 64(6):1085-91. PubMed ID: 21439678
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Irritation potential of tretinoin gel microsphere pump versus adapalene plus benzoyl peroxide gel.
    Leyden JJ; Nighland M; Rossi AB; Ramaswamy R
    J Drugs Dermatol; 2010 Aug; 9(8):998-1003. PubMed ID: 20684151
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effect of benzoyl peroxide on acne.
    Cunliffe WJ; Holland KT
    Acta Derm Venereol; 1981; 61(3):267-9. PubMed ID: 6167116
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reduction of Inflammatory and Noninflammatory Lesions with Topical Tyrothricin 0.1% in the Treatment of Mild to Severe Acne Papulopustulosa: A Randomized Controlled Clinical Trial.
    Richter C; Trojahn C; Hillmann K; Dobos G; Stroux A; Kottner J; Blume-Peytavi U
    Skin Pharmacol Physiol; 2016; 29(1):1-8. PubMed ID: 26458265
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Randomized, observer-blind, split-face study to compare the irritation potential of 2 topical acne formulations over a 14-day treatment period.
    Ting W
    Cutis; 2012 Aug; 90(2):91-6. PubMed ID: 22988653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.